Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania

被引:19
|
作者
Paulozzi, Leonard J. [1 ]
Stier, Daniel D. [2 ]
机构
[1] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA
[2] William Mitchell Coll Law, Publ Hlth Law Network, St Paul, MN USA
关键词
opioid; overdose; regulation; drug abuse; poisoning; mortality; UNITED-STATES;
D O I
10.1057/jphp.2010.27
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Drug overdose mortality nearly doubled in the United States from 1999 to 2004, with most of the increase due to prescription drug overdoses. Studying mortality rates in states that did not experience such increases may identify successful prescription overdose prevention strategies. We compared New York, a state that did not experience an overdose increase, with its neighbor, Pennsylvania. New York and Pennsylvania had prescription drug monitoring programs (PDMPs), but New York's PDMP was better funded and made use of serialized, tamperproof prescription forms. Per capita usage of the major prescription opioids in New York was two-thirds that of Pennsylvania. The drug overdose death rate in Pennsylvania was 1.6 times that of New York in 2006. Differences between New York and Pennsylvania might be due to the regulatory environment in New York State. Journal of Public Health Policy (2010) 31, 422-432. doi:10.1057/jphp.2010.27
引用
收藏
页码:422 / 432
页数:11
相关论文
共 50 条
  • [1] Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania
    Leonard J Paulozzi
    Daniel D Stier
    Journal of Public Health Policy, 2010, 31 : 422 - 432
  • [2] Prescription drug overdoses: A review
    Paulozzi, Leonard J.
    JOURNAL OF SAFETY RESEARCH, 2012, 43 (04) : 283 - 289
  • [3] State Prescription Drug Monitoring Programs and Fatal Drug Overdoses
    Nam, Young Hee
    Shea, Dennis G.
    Shi, Yunfeng
    Moran, John R.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (05) : 297 - U131
  • [4] Prescription Drug Monitoring Programs and Opioid Overdoses Exploring Sources of Heterogeneity
    Castillo-Carniglia, Alvaro
    Ponicki, William R.
    Gaidus, Andrew
    Gruenewald, Paul J.
    Marshall, Brandon D. L.
    Fink, David S.
    Martins, Silvia S.
    Rivera-Aguirre, Ariadne
    Wintemute, Garen J.
    Cerda, Magdalena
    EPIDEMIOLOGY, 2019, 30 (02) : 212 - 220
  • [5] Prescription Drug Monitoring Programs and Death Rates from Drug Overdose
    Paulozzi, Leonard J.
    Kilbourne, Edwin M.
    Desai, Hema A.
    PAIN MEDICINE, 2011, 12 (05) : 747 - 754
  • [6] Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses A Systematic Review
    Fink, David S.
    Schleimer, Julia P.
    Sarvet, Aaron
    Grover, Kiran K.
    Delcher, Chris
    Castillo-Carniglia, Alvaro
    Kim, June H.
    Rivera-Aguirre, Ariadne E.
    Henry, Stephen G.
    Martins, Silvia S.
    Cerda, Magdalena
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (11) : 783 - +
  • [7] Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention
    Dasgupta, Nabarun
    Sanford, Catherine
    Albert, Susan
    Brason, Fred Wells, II
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2010, 4 (01) : 32 - 37
  • [8] Drug overdoses
    Eyer, F.
    Zilker, T.
    NOTFALL & RETTUNGSMEDIZIN, 2012, 15 (07): : 569 - 576
  • [9] Association of prescription drug monitoring program laws with bedridden and missed work days
    Wetzel, Martha
    Yarbrough, Courtney R.
    von Esenwein, Silke A.
    Hockenberry, Jason M.
    HEALTH SERVICES RESEARCH, 2021, 56 (06) : 1215 - 1221
  • [10] Are prescription drug monitoring laws effective for all? Evidence from administrative data
    Gupta, Sumedha
    Al Achkar, Morhaf
    Ray, Bradley
    CONTEMPORARY ECONOMIC POLICY, 2022, 40 (01) : 28 - 47